Programmed cell death and in particular apoptosis is a crucial process in animal development and in the maintenance of cellular homeostasis. In Caenorhabditis elegans, the key activator of the central apoptotic pathway is the BH3-only protein EGL-1. EGL-1 is conserved and functions as a receiver of apoptotic stimuli [1-4]. EGL-1 activity is controlled at the level of expression; however, until now, the epigenetic regulation of
egl-1 expression with regard to the chromatin state of its locus has not been analyzed yet.To address this, we plan to visualize specific DNA sequences of the
egl-1 locus using the fluorescent CRISPR/Cas system to reveal their positions in the chromatin during embryonic development. To that end, we are using a system that has been developed for mammalian cells and adapt it for C. elegans by generating an inactive version of the Cas9 endonuclease fused with GFP (dCas9-GFP) [5,6]. As proof of concept, we are currently working on labeling the telomeres of developing embryos by co-expression of dCas9-GFP along with a small guide RNA (gRNA) targeting telomeric repeats.Generating multiple different gRNAs covering the
egl-1 locus should provide sufficient labeling and can be applied to any loci lacking repetitive sequences. Due to the absence of cell deaths during the first embryonic cell divisions, we expect to see a condensed state of the
egl-1 locus early during embryonic development, which presumably changes to an open state before the first wave of cell death (9th round of cell division). In case we can observe a change in chromatin state, we will investigate its role in the regulation of
egl-1 expression.1. Conradt, B. & Horvitz, H. R. The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell 93, 519-29 (1998).2. Nehme, R. & Conradt, B.
egl-1: a key activator of apoptotic cell death in C. elegans. Oncogene 27 Suppl 1, S30-S40 (2008).3. Youle, R. J. & Strasser, A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9, 47-59 (2008).4. Labi, V., Erlacher, M., Kiessling, S. & Villunger, a. BH3-only proteins in cell death initiation, malignant disease and anticancer therapy. Cell Death Differ. 13, 1325-1338 (2006).5. Anton, T., Bultmann, S., Leonhardt, H. & Markaki, Y. Visualization of specific DNA sequences in living mouse embryonic stem cells with a programmable fluorescent CRISPR/Cas system. Nucleus 5, 163-72 (2014).6. Chen, B. et al. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155, 1479-1491 (2013).